Nishtman Dizeyi (Former)
11 – 20 of 39
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Enzalutamide as a second generation antiandrogen for treatment of advanced prostate cancer
(
- Contribution to journal › Scientific review
-
Mark
Cyclin A1 modulates the expression of vascular endothelial growth factor and promotes hormone-dependent growth and angiogenesis of breast cancer.
(
- Contribution to journal › Article
-
Mark
Expression and localization of serotonin receptors in human breast cancer.
(
- Contribution to journal › Article
-
Mark
Interaction between c-jun and Androgen Receptor Determines the Outcome of Taxane Therapy in Castration Resistant Prostate Cancer.
(
- Contribution to journal › Article
- 2012
-
Mark
Regional distribution of neuroendocrine cells in the urogenital duct system of the male rat
(
- Contribution to journal › Article
-
Mark
Expression of Serotonin Receptors 5-HT1A, 5-HT1B, 5-HT2B and 5-HT4 in Ovary and in Ovarian Tumours.
(
- Contribution to journal › Article
- 2011
-
Mark
C-JUN INTERVENES WITH DOCETAXEL THERAPY IN CASTRATION-RESISTANT PROSTATE CANCER: AR STILL MATTERS
2011) 26th Annual Congress of the European Association of Urology In European Urology Supplements 10(2). p.294-294(
- Contribution to journal › Published meeting abstract
-
Mark
Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines.
(
- Contribution to journal › Article
- 2010
-
Mark
Properties and effects of a novel liquid crystal nanoparticle formulation of docetaxel in a prostate cancer mouse model.
(
- Contribution to journal › Article
- 2009
-
Mark
CYCLIN A1 MEDIATES DRUG-RESISTANT METASTATIC SPREAD OF PCA CELLS IN XENOGRAFTS IN VIVO
2009) 24th Annual Congress of the European Association of Urology In European Urology Supplements 8(4). p.343-343(
- Contribution to journal › Published meeting abstract